Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of larger size

Journal of Thyroid Research

Volumn 2012, Issue , 2012, Pages

  Zafon, Carles ^a   Obiols, Gabriel ^a   Baena, Juan Antonio ^a   Castellví, Josep ^a   Dalama, Belen ^a   Mesa, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CHEMOLUMINESCENCE; CLINICAL EXAMINATION; COHORT ANALYSIS; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; DIFFERENTIATED THYROID CANCER; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NEEDLE BIOPSY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THYROID CANCER; THYROID CANCER OF LARGER SIZE; THYROID CARCINOMA; THYROID DISEASE; THYROID NODULE; THYROID SURGERY; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TUMOR VOLUME;

EID: 84859519264     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.1155/2012/530721     Document Type: Article

References (18)

1. Cooper D. S., Doherty G. M., Haugen B. R., Kloos R. T., Lee S. L., Mandel S. J., Mazzaferri E. L., McIver B., Pacini F., Schlumberger M., Sherman S. I., Steward D. L., Tuttle R. M., Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 11 1167 1214 2-s2.0-70449370231 10.1089/thy.2009.0110
2. Biondi B., Cooper D. S., Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 2010 20 2 135 146 2-s2.0-77149121414 10.1089/thy.2009.0311
3. García-Jiménez C., Santisteban P., TSH Signalling and Cancer. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 5 654 671 2-s2.0-35348858942
4. Boelaert K., Horacek J., Holder R. L., Watkinson J. C., Sheppard M. C., Franklyn J. A., Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology and Metabolism 2006 91 11 4295 4301 2-s2.0-33751538065 10.1210/jc.2006-0527 (Pubitemid 44833401)
5. Boelaert K., The association between serum TSH concentration and thyroid cancer. Endocrine-Related Cancer 2009 16 4 1065 1072 2-s2.0-72549096515 10.1677/ERC-09-0150
6. Fiore E., Rago T., Provenzale M. A., Scutari M., Ugolini C., Basolo F., Di Coscio G., Berti P., Grasso L., Elisei R., Pinchera A., Vitti P., Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer 2009 16 4 1251 1260 2-s2.0-72549095371 10.1677/ERC-09-0036
7. Haymart M. R., Repplinger D. J., Leverson G. E., Elson D. F., Sippel R. S., Jaume J. C., Chen H., Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology and Metabolism 2008 93 3 809 814 2-s2.0-40849106396 10.1210/jc.2007-2215 (Pubitemid 351398557)
8. Gerschpacher M., Göbl C., Anderwald C., Gessl A., Krebs M., Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid 2010 20 4 389 392 2-s2.0-77952385766 10.1089/thy.2009.0139
9. Davies L., Welch H. G., Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 2006 295 18 2164 2167 2-s2.0-33646442046 10.1001/jama.295.18.2164
10. Leenhardt L., Grosclaude P., Chérié-Challine L., Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the french thyroid cancer committee. Thyroid 2004 14 12 1056 1060 2-s2.0-11344253462 10.1089/thy.2004.14.1056 (Pubitemid 40076130)
11. Lloyd R., de Lellis R., Heitz P., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Endocrine Organs 2004 Lyon, France IARC Press
12. Noguchi S., Yamashita H., Uchino S., Watanabe S., Papillary microcarcinoma. World Journal of Surgery 2008 32 5 747 753 2-s2.0-42449100315 10.1007/s00268-007-9453-0
13. Haymart M. R., Glinberg S. L., Liu J., Sippel R. S., Jaume J. C., Chen H., Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clinical Endocrinology 2009 71 3 434 439 2-s2.0-68949212088 10.1111/j.1365-2265.2008.03489.x
14. Jonklaas J., Nsouli-Maktabi H., Soldin S. J., Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 2008 18 9 943 952 2-s2.0-51849112468 10.1089/thy.2008.0061
15. Polyzos S. A., Kita M., Efstathiadou Z., Poulakos P., Slavakis A., Sofianou D., Flaris N., Leontsini M., Kourtis A., Avramidis A., Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. Journal of Cancer Research and Clinical Oncology 2008 134 9 953 960 2-s2.0-49649117179 10.1007/s00432-008-0373- 7
16. Jin J., Machekano R., McHenry C. R., The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. American Journal of Surgery 2010 199 3 294 298 2-s2.0-77649308577 10.1016/j.amjsurg.2009.08.028
17. Fiore E., Rago T., Provenzale M. A., Scutari M., Ugolini C., Basolo F., Di Coscio G., Miccoli P., Grasso L., Pinchera A., Vitti P., L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocrine-Related Cancer 2010 17 1 231 239 2-s2.0-77449090922 10.1677/ERC-09-0251
18. Franco A. T., Malaguarnera R., Refetoff S., Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proceedings of the National Academy of Sciences of the United States of America 2011 108 4 1615 16203